The 16th Annual Scientific Meeting of the Society for Biological Therapy (SBT) will be held November 9-11, 2001 at the Natcher Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.
The first day of the meeting will feature a Keynote Address by Steven A. Rosenberg, MD, PhD, Chief of the Surgery Branch at the National Cancer Institute in Bethesda, Maryland. The Saturday session will feature a Keynote Address by William A. Haseltine, PhD, Chairman and CEO of Human Genome Sciences, Inc. in Rockville, Maryland.
SBT’s distinguished faculty will lead sessions featuring the most up-to-date information available on various cancer biological therapies. Sessions will include cytokines, angiogenesis, antibodies, vaccine/dendritic cells, gene therapy, pharmacogenomics/discovery research, and new agents in development.
In addition to the scheduled scientific sessions, this year’s meeting will include, a Friday evening Cocktail Reception, a Saturday Member’s Lunch, and a Saturday evening Presidential Reception. These activities will provide meeting attendees with an opportunity to network with other professionals in cancer research. Daily poster sessions will also be available.